Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency: Commentary

Annals of Internal Medicine

Volumn 152, Issue 8, 2010, Pages

  Kociol, Robb D ^a   Newby, L Kristin ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; IRON DERIVATIVE; PLACEBO; UNCLASSIFIED DRUG;

AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IRON DEFICIENCY; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 77954847982     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-8-201004200-02005     Document Type: Note

References (0)